Arcus Biosciences Inc (RCUS)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-330,000	-318,000	-293,000	-270,000	-340,000	-323,000	-313,000	-299,000	-280,000	75,019	66,883	59,747	54,000	-278,796	-199,108	-168,347	-124,000	-89,750	-114,551	-98,336
Revenue (ttm)	US$ in thousands	258,000	263,000	247,000	237,000	117,000	119,355	121,236	118,995	112,000	433,144	408,724	399,137	398,304	53,292	108,361	92,939	77,517	77,780	15,000	15,000
Operating profit margin		-127.91%	-120.91%	-118.62%	-113.92%	-290.60%	-270.62%	-258.17%	-251.27%	-250.00%	17.32%	16.36%	14.97%	13.56%	-523.15%	-183.75%	-181.14%	-159.96%	-115.39%	-763.67%	-655.57%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-330,000K ÷ $258,000K
= -127.91%

The operating profit margin of Arcus Biosciences Inc has shown significant fluctuations over the observed periods. The company experienced negative operating profit margins in the range of -655.57% to -290.60% between March 31, 2020, and December 31, 2023. This indicates that during these periods, the company's operating expenses exceeded its revenues, resulting in negative profitability from its core operations.

However, there was a notable turnaround starting from December 31, 2021, with the operating profit margin improving to 13.56%. This positive trend continued in the following quarters, reaching 16.36% by June 30, 2022. The company maintained its profitability with operating profit margins ranging from 13.56% to 17.32% from December 31, 2021, to September 30, 2022.

Subsequently, there was a sharp decline in the operating profit margin, falling back into negative territory from December 31, 2022, to June 30, 2024. The margins during this period ranged from -250.00% to -127.91%. This indicates a reversal in profitability, potentially due to increased operating expenses or declining revenues.

Overall, the operating profit margin trend of Arcus Biosciences Inc demonstrates periods of financial challenges followed by improvements and subsequent declines. It is important for the company to consistently monitor and manage its operating expenses and revenues to maintain sustainable profitability in the long term.